GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Acrivon Therapeutics ACRV · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.58

-1.86%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Largest shareholders

As filed, so dates differ, and a group and its funds can both appear.

HolderSharesStakeChangeFiled
Blume-Jensen (Peter)2.2m6.93%−19.9k21 Aug 2025
Devroe (Eric)65.9k0.21%−61314 Aug 2025
BlackRock Advisors (UK) Limited16.9k0.05%+51030 Sept 2025
Gamelin (Erick)15.7k0.05%−40314 Aug 2025
Levy (Adam D.)12.2k0.04%−1.2k1 Aug 2025
Assenagon Asset Management S.A.10.2k0.03%−43630 Sept 2025
Miller (Mary)5k0.02%−84217 Oct 2025
Peterson (Katharine)4.2k0.01%−9914 Aug 2025
Dimensional Fund Advisors, Ltd.4.1k0.01%—30 Sept 2025
ProShare Advisors LLC1.1k0.00%+2030 Sept 2025
NISA Investment Advisors, L.L.C.5840.00%—30 Sept 2025
Carson Wealth Management Group1270.00%−66330 Sept 2025
L2 Asset Management, LLC720.00%—31 Aug 2025

Short interest

Shares sold short, 15 Oct 2026. US exchange data.

1.7m

+7.5% on the period before. 6.6 days to cover.

Short volume

Share of the day's trading sold short, 5 Nov 2026

77.5%

Last 60 trading days.

Failed deliveries

Shares not delivered on settlement, from the SEC

  • 29 Sept 2026213 shares
  • 14 Aug 20263,149 shares

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.